KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in LH — Labcorp Holdings Inc.
CIK 1021223
LOS ANGELES, CA
Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,080
-$388 QoQ
Shares Held
11
-15.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#989
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $60,485,013 across 14 Diagnostics & Research names. LH ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
83,104 | $43,749,269 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
11,132 | $5,581,139 | |
| 3 | DHR |
Danaher Corp /De/
|
28,135 | $5,359,154 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
2,866 | $3,661,343 | |
| 5 | DGX |
Quest Diagnostics Inc
|
4,959 | $1,051,060 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
4,711 | $910,259 | |
| 7 | NTRA |
Natera, Inc.
|
302 | $81,977 | |
| 8 | GRAL |
GRAIL, Inc.
|
592 | $40,415 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,080 | 11 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,468 | 13 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,261 | 13 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,731 | 13 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,412 | 13 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,560 | 11 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,522 | 11 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $2,458 | 11 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,238 | 11 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||